Regulation of Neph3 gene in podocytes--key roles of transcription factors NF-kappaB and Sp1.
BACKGROUND
Neph3 (filtrin) is expressed in the glomerular podocytes where it localizes at the specialized cell adhesion structures of the foot processes called slit diaphragms which form the outermost layer of the glomerular filtration barrier. Neph3 protein shows homology and structural similarity to Neph1, Neph2 and nephrin, which all are crucial for maintaining the normal glomerular ultrafiltration function. The exact function of Neph3 in the kidney is not known but we have previously shown that the level of Neph3 mRNA is decreased in proteinuric diseases. This suggests that Neph3 may play a role in the pathogenesis of kidney damage, and emphasizes the need to analyze the regulatory mechanisms of Neph3 gene. In this study we investigated the transcriptional regulation of Neph3 gene by identifying transcription factors that control Neph3 expression.


RESULTS
We cloned and characterized approximately 5 kb fragment upstream of the Neph3 gene. Neph3 proximal promoter near the transcription start site was found to be devoid of TATA and CAAT boxes, but to contain a highly GC-rich area. Using promoter reporter gene constructs, we localized the main activating regulatory region of Neph3 gene in its proximal promoter region from -105 to -57. Within this region, putative transcription factor binding sites for NF-kappaB and Sp1 were found by computational analysis. Mutational screening indicated that NF-kappaB and Sp1 response elements are essential for the basal transcriptional activity of the Neph3 promoter. Co-transfection studies further showed that NF-kappaB and Sp1 regulate Neph3 promoter activity. In addition, overexpression of NF-kappaB increased endogenous Neph3 gene expression. Chromatin immunoprecipitation assay using cultured human podocytes demonstrated that both NF-kappaB and Sp1 interact with the Neph3 promoter.


CONCLUSIONS
Our results show that NF-kappaB and Sp1 are key regulators of Neph3 expression at the basal level in podocytes, therefore providing new insight into the molecular mechanisms that contribute to the expression of Neph3 gene.
Ristola
Mervi
M
Department of Bacteriology and Immunology, Haartman Institute, P,O, Box 21, 00014 University of Helsinki, Finland. mervi.ristola@helsinki.fi
Arpiainen
Satu
S
Saleem
Moin A
MA
Mathieson
Peter W
PW
Welsh
Gavin I
GI
Lehtonen
Sanna
S
Holthöfer
Harry
H
D002460:Cell Line; D005786:Gene Expression Regulation; D006801:Humans; D007136:Immunoglobulins / Q000235:genetics* / Q000378:metabolism; D008565:Membrane Proteins / Q000235:genetics* / Q000378:metabolism; D016328:NF-kappa B / Q000235:genetics / Q000378:metabolism*; D050199:Podocytes / Q000378:metabolism*; D011401:Promoter Regions, Genetic; D011485:Protein Binding; D020218:Response Elements; D016329:Sp1 Transcription Factor / Q000235:genetics / Q000378:metabolism*
D007136:Immunoglobulins; C482646:KIRREL2 protein, human; D008565:Membrane Proteins; D016328:NF-kappa B; D016329:Sp1 Transcription Factor
Biochem Biophys Res Commun. 2005 Dec 30;338(4):1818-24
16288986
Trends Biochem Sci. 1999 Jun;24(6):236-40
10366853
J Am Soc Nephrol. 2003 Apr;14(4):981-91
12660332
Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):7962-7
10393930
Arch Biochem Biophys. 2008 Jun 1;474(1):143-9
18396147
J Am Soc Nephrol. 2003 Nov;14(11):2958-66
14569107
Mol Cell. 1998 Mar;1(4):575-82
9660941
Nephrol Dial Transplant. 2004 Oct;19(10):2505-12
15280531
J Biol Chem. 2003 May 23;278(21):19266-71
12646566
Mol Cell Biochem. 2007 Jan;294(1-2):117-25
16841182
Biochem Biophys Res Commun. 2008 Jul 18;372(1):1-13
18364237
J Nephrol. 2001 Mar-Apr;14(2):98-103
11411021
Nephrol Dial Transplant. 2007 Jul;22(7):1903-9
17442742
Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):646-51
11209060
BMC Mol Biol. 2006 May 09;7:17
16684343
Am J Pathol. 1999 Nov;155(5):1681-7
10550324
Cell. 1988 Dec 2;55(5):887-98
3142690
Invest Ophthalmol Vis Sci. 2004 Jul;45(7):2299-305
15223809
J Cell Biochem. 2005 Feb 1;94(2):257-65
15546139
Nucleic Acids Res. 1999 Aug 1;27(15):2991-3000
10454592
Genes Dev. 1994 Oct 1;8(19):2282-92
7958895
J Am Soc Nephrol. 2004 Nov;15(11):2851-6
15504938
J Am Soc Nephrol. 2002 Mar;13(3):630-638
11856766
Kidney Int. 1999 Oct;56(4):1481-91
10504499
Biochim Biophys Acta. 2006 May;1759(5):247-56
16806531
J Am Soc Nephrol. 2004 Dec;15(12):3044-51
15579507
EMBO J. 1993 Sep;12(9):3551-8
8253080
J Virol. 1994 Nov;68(11):7131-8
7933095
Mol Cell Biol. 2001 Jul;21(14):4829-36
11416156
Am J Kidney Dis. 2005 Jan;45(1):54-65
15696444
Am J Physiol Renal Physiol. 2006 Mar;290(3):F657-65
16204413
Lab Invest. 2007 Mar;87(3):273-83
17260001
FASEB J. 2003 Jan;17(1):115-7
12424224
Am J Physiol Renal Physiol. 2001 Oct;281(4):F579-96
11553505
Hum Mol Genet. 2001 Jan 1;10(1):1-8
11136707
Gene. 1999 Oct 1;238(2):291-300
10570957
Neurosci Res. 2005 Jul;52(3):250-62
15927725
Nephrol Dial Transplant. 2004 Feb;19(2):380-5
14736962
J Am Soc Nephrol. 2002 Jun;13(6):1586-94
12039988
J Hypertens. 2002 May;20(5):985-92
12011660
Kidney Int. 2001 Mar;59(3):923-31
11231347
Genomics. 2003 Aug;82(2):130-42
12837264
J Am Soc Nephrol. 2006 Jun;17(6):1624-32
16687628
Annu Rev Immunol. 2000;18:621-63
10837071
J Am Soc Nephrol. 2005 Jun;16(6):1693-702
15843475
Mol Cell Biol. 1994 Oct;14(10):6570-83
7935378
Annu Rev Immunol. 1996;14:649-83
8717528
Biochem Biophys Res Commun. 2003 Jan 10;300(2):364-70
12504092